WCO classification path
- Chapter30Pharmaceutical products
- Heading3006Pharmaceutical goods specified in note 4 to this chapter
- Subheading300630Opacifying preprations for X-ray examinations; diagnostic reagents designed to be administered to the patient
- National300630000Opacifying preparations for X-ray examinations; diagnostic reagents designed to be administered to the patient
300630000
"Opacifying preparations for X-ray examinations; diagnostic reagents designed to be administered to the patient"
HS code 300630000 (Chapter 30 "Pharmaceutical products"; Heading 3006 "Pharmaceutical goods specified in note 4 to this chapter"; Subheading 300630 "Opacifying preprations for X-ray examinations; diagnostic reagents designed to be administered to the patient") under the Japan tariff schedule classifies "Opacifying preparations for X-ray examinations; diagnostic reagents designed to be administered to the patient". Japan customs apply General rate of Free, WTO rate (Free). Statutory unit of measure: KG (I.I.). This commodity is subject to 2 import regulations or restrictions; see compliance section below. 21 free trade agreement preferential rates are available for this code.
Tariff Schedule
| Classification | Rate |
|---|---|
一般税率 General rate | Free |
WTO 税率 WTO rate | (Free) |
FTA Preferential Rates
21 agreements available · certificate of origin required
| Agreement | Rate |
|---|---|
| Singapore | Free |
| Mexico | Free |
| Malaysia | Free |
| Chile | Free |
| Thailand | Free |
| Indonesia | Free |
| Brunei | Free |
| ASEAN | Free |
| Philippines | Free |
| Switzerland | Free |
| Vietnam | Free |
| India | Free |
| Peru | Free |
| Australia | Free |
| Mongolia | Free |
| CPTPP | Free |
| EU | Free |
| UK | Free |
| RCEP_ASEAN_AU_NZ | Free |
| RCEP_China | Free |
| RCEP_Korea | Free |
Compliance & Controls
2 import regulations, restrictions, or permit requirements
承認(北朝鮮産品(全品目)、鯨、ダイヤモンド等
Para. 2 approved items (whale,etc)
医薬品、医療機器等の品質、有効性及び安全性の確保等に関する法律
Act on Securing Quality,Efficacy and Safety of Pharmaceuticals, Medical Devices, Regenerative and Cellular Therapy Products, Gene Therapy Products, and Cosmetic Law
Global Benchmark
HS-6 prefix 3006.30 across other jurisdictions